India’s exports included extracts of medicinal herbs, Ayurveda medicines, dietary supplements, nutraceuticals and herbal supplements. The data presented by the minister show a gradually increase of AYUSH products in foreign countries.
The minister also informed that India has for the first time successfully engaged with United States in the field of traditional medicine.
An India-US workshop on traditional medicine with special focus on cancer was organised on 3-4 March, 2016 at New Delhi. A US team comprising of experts from National Cancer Institute (NCI) took part in the two-day exhaustive deliberations that have resulted into significant leads.
“A productive bilateral dialogue with Department of Health and Human Services (DHHS), National Institute of Health (NIH) and National Cancer Institute (NCI) team is ongoing,” Naik said.
Giving details of the drug standardisation, the minister said the Ministry of AYUSH has set-up Central Council for Research in Ayurvedic Sciences (CCRAS) as the apex body for formulation and development of Ayurvedic medicines for various diseases.
As many as 88 singles drugs and 33 compound formulations were carried out under drug standardisation in the year 2016-17, according to the minister.